May 23 (Reuters) - Inhalation Sciences Sweden AB ISAB.TE :
* INHALATION SCIENCES AB (PUBL) INITIATES STUDY TO VALIDATE
PRECISEINHALE FOR CLINICAL USE
* TECHNICAL AND REGULATORY VALIDATION IS EXPECTED TO TAKE
ABOUT 15
MONTHS
* CLINICAL VALIDATION STUDY AIMS FOR BOTH TECHNICAL AND
REGULATORY
VALIDATION OF PRECISEINHALE FOR USE IN CLINICAL STUDIES OF
INHALABLE SUBSTANCES
* TECHNICAL AND REGULATORY VALIDATION WILL BE FULLY FINANCED
THROUGH DIVESTMENT OF A SMALL PART OF ISAB'S HOLDINGS IN ZICCUM
AB
Source text for Eikon: ID:nWkr77Dvg0
Further company coverage: ISAB.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))